Publications by authors named "Craig R Shadle"

Claim this Profile
P
Pharmacokinetic and pharmacodynamic interactions between the hepatitis C virus protease inhibitor, boceprevir, and the oral contraceptive ethinyl estradiol/norethindrone.
Wen H Lin, Hwa-Ping Feng, Craig R Shadle, Terry O'Reilly, John A Wagner

Eur J Clin Pharmacol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Single-Dose Bioequivalence and Food Effect Study With Aprepitant and Fosaprepitant Dimeglumine in Healthy Young Adult Subjects.
Craig R Shadle, M Gail Murphy, Yang Liu, Maureen Ho, Daniel Tatosian

Clin Pharmacol Drug Dev· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of oral dexamethasone and midazolam when administered with single-dose intravenous 150 mg fosaprepitant in healthy adult subjects.
Thomas C Marbury, Phung L Ngo, Craig R Shadle, Bo Jin, Deborah Panebianco

J Clin Pharmacol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of effect of aprepitant or its prodrug fosaprepitant on QTc intervals in healthy subjects.
Thomas C Marbury, Bo Jin, Deborah Panebianco, M Gail Murphy, Hong Sun, Craig R Shadle

Anesth Analg· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of potential inductive effects of aprepitant on cytochrome P450 3A4 and 2C9 activity.
Craig R Shadle, Yih Lee, Anup K Majumdar, Kevin J Petty, Cynthia Gargano

J Clin Pharmacol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis